source
- Moderna's mRNA flu vaccine mFLUVISA receives FDA approval after earlier filing refusalThe U.S. Food and Drug Administration initially issued a refusal-to-file letter to Moderna's flu vaccine in February, but a few days later reversed that decision and accepted a revised submission f…
- Replimune's oncolytic virus therapy Tudriqev receives FDA accelerated approval for advanced melanomaThe U.S. Food and Drug Administration has granted approval to Replimune's melanoma treatment, ending a series of earlier rejections after an advisory panel advocated for the drug. The therapy, pre…